Microbiota‐Derived Inosine Suppresses Systemic Autoimmunity via Restriction of B Cell Differentiation and Migration
Advanced Science · 2025
DOI: 10.1002/advs.202409837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Lingyu Gao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, 210042, China. Hauptthemen laut MEDLINE: B-Lymphocytes, Gastrointestinal Microbiome, Inosine, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Special Program of National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences (CIFMS) No.
Abstract (Originalsprache)
The role of gut microbiota dysbiosis in systemic lupus erythematosus (SLE) pathogenesis remains elusive. Here, it is shown that fecal microbiota transplantation (FMT) from healthy mice to lupus mice ameliorates lupus‐like symptoms. Microbiota reconstitution effectively reduces systemic class switch recombination (CSR) and elevates immunoglobulin heavy chain (IGH) naïve isotype. Microbiota profiling reveals an enrichment of Lactobacillus johnsonii post‐FMT, with a significant correlation to purine metabolites. Importantly, the L. johnsonii ‐derived inosine, an intermediate metabolite in purine metabolism, effectively alleviates lupus pathogenesis in mice. Inosine inhibits B cell differentiation and reduces renal B cell infiltration to protect mice from lupus. At the molecular level, inosine reprograms B cells through the extracellular signal‐regulated kinase (ERK)‐hypoxia‐inducible factor‐1alpha (HIF‐1α) signaling pathway. Therefore, this study highlights the discovery of a novel microbial metabolite modulating autoimmunity and suggests its potential for innovative microbiome‐based therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, 210042, China.
- Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, 210042, China.
- Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, 210042, China.
- Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, 410013, China.
- Clinical Laboratory, The Second Hospital of Anhui Medical University, Hefei, 230601, China.
- Department of Microbiology, and Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
ORCID-Profile: Qianjin Lu
Förderung
- National Key R&D Program of China
- Special Program of National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences (CIFMS) No
- Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
- Key Program of the National Natural Science Foundation of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Gao, L., Zhang, Y., Hu, Z., Chen, S., Wang, Q., Zeng, Y., Yin, H., Zhao, J., Zhan, Y., Gao, C., Xin, Y., Chen, B., van der Veen, S., Zhao, M., Fang, D., & Lu, Q. (2025). Microbiota‐Derived Inosine Suppresses Systemic Autoimmunity via Restriction of B Cell Differentiation and Migration. Advanced Science. https://doi.org/10.1002/advs.202409837
Vancouver
Gao L, Zhang Y, Hu Z, Chen S, Wang Q, Zeng Y, et al. Microbiota‐Derived Inosine Suppresses Systemic Autoimmunity via Restriction of B Cell Differentiation and Migration. Advanced Science. 2025. doi:10.1002/advs.202409837
BibTeX
@article{Gao2025,
author = {Gao, Lingyu and Zhang, Yuhan and Hu, Zhi and Chen, Shengwen and Wang, Qiaolin and Zeng, Yong and Yin, Huiqi and Zhao, Junpeng and Zhan, Yijing and Gao, Changxing and Xin, Yue and Chen, Bing and van der Veen, Stijn and Zhao, Ming and Fang, Deyu and Lu, Qianjin},
title = {Microbiota‐Derived Inosine Suppresses Systemic Autoimmunity via Restriction of B Cell Differentiation and Migration},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202409837}
}
EUVIMED